Synonyms:adenosine, 58-61-7, Adenocard, Adenoscan, Adenine riboside, beta-D-Adenosine, Nucleocardyl, Adenosin, Boniton, Sandesin, Myocol, Adenine nucleoside, Adenocor, beta-Adenosine, 9-beta-D-Ribofuranosyladenine, 9-beta-D-Ribofuranosidoadenine, 9-beta-D-Ribofuranosyl-9H-purin-6-amine, Adenosin [German], USAF CB-10, 9beta-D-Ribofuranosyladenine, 6-Amino-9-beta-D-ribofuranosyl-9H-purine, Ade-Rib, Caswell No. 010B, (2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol, SR 96225, Adenosine [USAN:BAN], (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol, beta-D-Ribofuranoside, adenine-9, 6-Amino-9beta-D-ribofuranosyl-9H-purine, (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, CHEBI:16335, Quinquefolan B, 3H-adenosine, NSC 7652, Dehydran 240, SR-96225, 9-.beta.-d-Ribofuranosyladenine, Adenosine (Adenocard), AI3-52413, 9H-Purin-6-amine, 9beta-D-ribofuranosyl-, CHEMBL477, Adenine riboside;D-Adenosine, D-Adenosine, beta-D-Ribofuranose, 1-(6-amino-9H-purin-9-yl)-1-deoxy-, adenine-D-ribose, DTXSID1022558, K72T3FS567, NSC-7652, CCRIS 2557, 9-?-D-Ribofuranosyl-9H-purin-6-amine, NCGC00023673-05, Pallacor, 41547-82-4, MFCD00005752, 109767-06-8, 133248-01-8, DTXCID902558, .beta.-D-Adenosine, CAS-58-61-7, Adenocard (TN), Adenoscan (TN), SMR000058216, MEDR-640, Adenosine (JAN/USP), SR-05000001981, EINECS 200-389-9, Adenine-beta-D-arabinofuranoside, NSC 627048, NSC7652, Adenogesic, Adenosine [USAN:USP:BAN], Adenin riboside, UNII-K72T3FS567, .beta.-D-Ribofuranoside, adenine-9, 9-.alpha.-D-Arabinofuranosyladenine, NSC627048, b-D-Adenosine, HSDB 7774, SUN-Y4001, N6-Methylado, 1dgm, 1odi, 2fqy, 2ydo, 3axz, 4cki, 4ckj, Adenosine,(S), beta-delta-Adenosine, [U-14C]adenosine, 6-Amino-9.beta.-D-ribofuranosyl-9H-purine, 2gl0, 3ay0, 4pd9, Adenosine, >=99%, ADENOSINE [JAN], ADENOSINE [MI], 6-Amino-9-.beta.-ribofuranosyl-9H-purine, ADENOSINE [HSDB], ADENOSINE [INCI], ADENOSINE [USAN], Spectrum2_001257, Spectrum3_000288, ADENOSINE [VANDF], cid_191, SCHEMBL731, ADENOSINE [MART.], bmse000061, bmse000996, Epitope ID:140947, ADENOSINE [USP-RS], ADENOSINE [WHO-DD], 4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside, 9-ss-D-Ribofuranosyladenine, BSPBio_001796, .beta.-D-Ribofuranose, 1-(6-amino-9H-purin-9-yl)-1-deoxy-, cid_60961, MLS000069638, MLS002153227, MLS006010946, SPECTRUM1500107, Adenine-9-ss-D-ribofuranoside, REGID_for_CID_60961, SPBio_001194, adenine-9beta-D-Ribofuranoside, GTPL2844, 9beta-delta-Ribofuranosyladenine, ADENOSINE [EP IMPURITY], ADENOSINE [ORANGE BOOK], ADENOSINE [EP MONOGRAPH], BDBM14487, KBio3_001296, 9-beta-delta-Ribofuranosyladenine, ADENOSINE [USP MONOGRAPH], EA6C60C2-6AFB-4264-A2F0-541373DB950E, 9-.beta.-D-Ribofuranosidoadenine, 9-beta-delta-Ribofuranosidoadenine, adenine-9beta-delta-Ribofuranoside, Bio1_000437, Bio1_000926, Bio1_001415, HMS1920A13, HMS2091G13, HMS2235E24, HMS3884O04, Pharmakon1600-01500107, ACT02616, ALBB-032827, AMY30083, 9-beta-delta-Arabinofuranosyladenine, Tox21_110891, AC7861, CCG-38824, HB2843, NSC755857, s1647, AKOS015888594, Tox21_110891_1, AC-8229, AM83931, DB00640, NSC-755857, SDCCGMLS-0003108.P003, 9beta-D-ribofuranosyl-9H-Purin-6-amine, NCGC00023673-03, NCGC00023673-04, NCGC00023673-06, NCGC00023673-07, NCGC00023673-10, NCGC00023673-20, NCGC00178869-03, AC-27494, AS-12664, BP-58619, Adenosine, Vetec(TM) reagent grade, 98%, SBI-0206673.P002, 9beta-delta-ribofuranosyl-9H-Purin-6-amine, DB-022408, 6-Amino-9beta-delta-ribofuranosyl-9H-purine, 9-.beta.-D-Ribofuranosyl-9H-purin-6-amine, 9-beta-delta-Ribofuranosyl-9H-purin-6-amine, A0152, 9H-Purin-6-amine, 9-.beta.-d-ribofuranosyl-, C00212, D00045, EN300-100931, AB00384349-11, AB00384349_13, AB00384349_14, Adenosine, BioReagent, suitable for cell culture, Q190012, 6-AMINO-9-.BETA.-D-RIBOFURANOSYL-9H-PURINE, SR-05000001981-1, SR-05000001981-2, Z1341543331, 1-(6-amino-9H-purin-9-yl)-1-deoxy-beta-D-Ribofuranose, Adenosine, European Pharmacopoeia (EP) Reference Standard, Formycin A, from Streptomyces kaniharaensis, >=98% (HPLC), 1-(6-amino-9H-purin-9-yl)-1-deoxy-beta-delta-Ribofuranose, Adenosine, United States Pharmacopeia (USP) Reference Standard, Adenosine, Pharmaceutical Secondary Standard; Certified Reference Material, (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 142796-17-6
Pubchem:PUBCHEM:60961
Id:cc96a980-a0a9-5ad6-be7b-90c480f34328
Description:nan
